LIVE MARKET TRACKER :   BSE SENSEX   33455.79      |    NSE NIFTY 10322.25    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Indoco Remedies surges on the bourses

Indoco Remedies surges on the bourses (01-Aug-2016)

 Indoco Remedies is currently trading at Rs. 311.80, up by 3.35 points or 1.09% from its previous closing of Rs. 308.45 on the BSE.

The scrip opened at Rs. 309.90 and has touched a high and low of Rs. 314.00 and Rs. 306.00 respectively. So far 3011 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 363.00 on 18-Aug-2015 and a 52 week low of Rs. 244.00 on 25-Feb-2016.

Last one week high and low of the scrip stood at Rs. 338.95 and Rs. 297.85 respectively. The current market cap of the company is Rs. 2888.91 crore.

The promoters holding in the company stood at 59.24%, while Institutions and Non-Institutions held 20.71% and 20.05% respectively.

Indoco Remedies has received the approval from United States Food & Drug Administration (USFDA) to manufacture and market Allopurinol 100 mg & 300 mg tablets. Allopurinol is indicated for treatment of Gout. The market size of this product in the US is $169 million.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India. Indoco, a $ 149 million Company, employs over 5500 people including 300 skilled scientists. The Company has 8 manufacturing facilities, 5 of which are for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility

 

 


Top News Today
Tayo Rolls' workers file cases for payment of unpaid wages
(11-Dec-2017)

Tayo RollsTayo Rolls' workers have filed cases against the company for payment of their unpaid wages. The company has not been able to pay wages to its workmen due to paucity of funds. Tayo Rolls is a metal fabrication......click on news to read complete article.

Tata Motors to increase prices of Passenger Vehicles
(11-Dec-2017)

Tata Motors to increase prices of Passenger VehiclesTata Motors is planning to increase prices of its entire passenger vehicles range by up to Rs 25,000, starting January 2018. This increase in price is due to rising input costs. The introductory prices......click on news to read complete article.

Jet Airways to induct 25 narrow-body planes in next 3 years
(11-Dec-2017)

Jet Airways to induct 25 narrow-body planes in next 3 yearsJet Airways is planning to induct almost 25 narrow-body planes into its fleet over the next three years even as it is yet to take a call on the delivery schedule of the Boeing 787 planes. Jet Airways is......click on news to read complete article.

International Stock News
Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

US markets closed higher; S&P snaps four-day losing streak
(08-Dec-2017)

US markets closed higher; S&P snaps four-day losing streakThe US markets closed higher on Thursday, with the S&P 500 snapping a four-session losing streak on the back of gains in the technology, industrials and materials sectors. Traders focused on continued......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.